These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [68Ga-PSMA-I&T PET/CT for assessment of tumor burden in primary lesions of treatmentnaïve prostate cancer]. Xie Y, Li C, Zhang L, Zang S, Yu F, Wang S, Wang F. Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug 20; 42(8):1143-1148. PubMed ID: 36073212 [Abstract] [Full Text] [Related]
13. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer. Sanli Y, Kuyumcu S, Sanli O, Buyukkaya F, İribaş A, Alcin G, Darendeliler E, Ozluk Y, Yildiz SO, Turkmen C. Ann Nucl Med; 2017 Nov 20; 31(9):709-717. PubMed ID: 28900854 [Abstract] [Full Text] [Related]
14. 68 Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer. Hruby G, Eade T, Emmett L, Ho B, Hsiao E, Schembri G, Guo L, Kwong C, Hunter J, Byrne K, Kneebone A. Asia Pac J Clin Oncol; 2018 Aug 20; 14(4):343-346. PubMed ID: 29663686 [Abstract] [Full Text] [Related]